Clinical Trial Update: A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating REGN9933 and REGN7508 for preventing venous thromboembolism in adults with a peripherally inserted central catheter has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• REGN7508
• REGN9933

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Venous Thromboembolism | Phase 2 | Status: COMPLETED